Clopidogrel in infants with systemic-to-pulmonary-artery shunts
Wessel, David L × Berger, Felix Li, Jennifer S Dähnert, Ingo Rakhit, Amit Fontecave, Sylvie Newburger, Jane W Gewillig, Marc CLARINET Investigators #
New England Journal of Medicine vol:368 issue:25 pages:2377-84
Infants with cyanotic congenital heart disease palliated with placement of a systemic-to-pulmonary-artery shunt are at risk for shunt thrombosis and death. We investigated whether the addition of clopidogrel to conventional therapy reduces mortality from any cause and morbidity related to the shunt.